PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Novel score predicts heart failure improvement after atrial fibrillation ablation

ANTWOORD study presented in a late breaking science session today at EHRA 2023

2023-04-18
(Press-News.org) Barcelona, Spain – 18 April 2023:  A score based on four readily available clinical and imaging parameters identifies the heart failure patients who benefit most from atrial fibrillation ablation, according to late breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).1

 

Atrial fibrillation and heart failure often coexist.2 It is estimated that approximately 30% of patients with heart failure will develop atrial fibrillation and patients with atrial fibrillation have a five-fold increased risk of developing heart failure.3 Each condition aggravates the prognosis of the other. Atrial fibrillation patients who develop heart failure have a three-fold increased risk of death, while in heart failure patients, the risk of death is two-fold higher when atrial fibrillation is also present.

 

Medium-sized randomised trials have produced mixed evidence on the benefit of ablation in patients with heart failure, with outcomes largely depending on the selection and characteristics of patients. Therefore, there is uncertainty about which heart failure patients should be referred for ablation. ESC Guidelines on atrial fibrillation recommend the procedure to reverse left ventricular dysfunction in atrial fibrillation patients when tachycardia-induced cardiomyopathy is highly probable. In addition, catheter ablation should be considered in selected atrial fibrillation patients with heart failure and reduced ejection fraction to improve survival and reduce heart failure hospitalisation.2

 

“The tools to help clinicians determine who exactly these selected patients are and which patients have tachycardia-mediated cardiomyopathy are elusive and often subjective,” said principal investigator Dr. Marco Bergonti of the Cardiocentro Ticino Institute - EOC, Lugano, Switzerland and a PhD student at the University of Antwerp, Belgium. “Further evidence is needed to help stratify and identify those patients who will most likely benefit from atrial fibrillation ablation. The Antwerp score was developed to predict the response to ablation in heart failure patients with impaired (below 50%) ejection fraction.”

 

The score is based on four parameters: QRS width above 120 milliseconds (2 points), known aetiology (2 points), paroxysmal atrial fibrillation (1 point) and severe atrial dilation (1 point). Total scores range from 0 to 6, with 0 indicating a greater likelihood of recovery. A previous single-centre study by the ANTWOORD investigators showed that the ANTWERP score estimated the probability of left ventricular ejection fraction (LVEF) recovery after ablation of atrial fibrillation.4

 

The current ANTWOORD study aimed to externally validate the ANTWERP score in a large European multicentre cohort. The researchers retrospectively identified patients with heart failure, impaired LVEF and atrial fibrillation who had an ablation procedure at eight centres in Europe. Participants underwent echocardiography to assess LVEF before ablation and 12 months afterwards. The primary endpoint was sufficient improvement in ejection fraction at the 12-month echocardiography to be considered a “Responder” to treatment. Responders were defined according to the 2021 universal definition of heart failure: 1) in patients with a baseline LVEF of 40–50%, an LVEF increase to 50% or more; 2) in those with a baseline LVEF of 40% or below, an increase in LVEF of at least 10% from baseline, and a second measurement of LVEF above 40%.5

 

The study included 605 patients. The average age was 61 years and 24% were women. Some 427 patients (70%) were classified as responders and were more likely to have positive ventricular remodelling (odds ratio [OR] 8.9, p<0.001), fewer heart failure hospitalisations (OR 0.09, p<0.001) and lower mortality (OR 0.11, p<0.001) compared to non-responders. The Antwerp score predicted LVEF improvement after ablation with an area under the curve of 0.86 (95% confidence interval 0.82–0.89; p<0.001). For total scores of 0, 1, 2, 3, 4, and 5-6, the proportion of responders was 94%, 92%, 82%, 51%, 40% and 17%, respectively.

 

Dr. Bergonti said: “Based on our findings, patients with a low score (2 or less) may benefit from early referral for catheter ablation, with a more than 90% chance of recovery. Patients with a high score (5 or higher) have a very low expected recovery rate (below 20%) and hence may benefit more from alternative strategies such as aggressive rate control. Those in the intermediate zone (score 3-4, expected recovery rate 47%) may benefit from further diagnostic tests such as cardiac magnetic resonance to improve their diagnostic assessment, as the presence of late gadolinium enhancement has been associated with less LVEF improvement.”

 

ENDS

END


ELSE PRESS RELEASES FROM THIS DATE:

IOP Publishing expands its open access environmental portfolio with the launch of Environmental Research: Energy

IOP Publishing expands its open access environmental portfolio with the launch of Environmental Research: Energy
2023-04-18
Responding to the increasing demand for sustainable energy research, IOP Publishing is launching a new open access (OA) environmental research journal. Environmental Research: Energy (EREN) will openly publish the latest findings around clean and sustainable energy for all. Aligned with a number of the UN’s Sustainable Development Goals (SDGs), the journal launch comes at a time when research output around renewable energy and sustainability has seen a 600% increase compared to ten years ago.  Environmental Research: Energy is the latest addition to IOP Publishing's expanding Environmental Research ...

Novel ablation strategy improves freedom from arrhythmias in atrial fibrillation patients

2023-04-18
Barcelona, Spain – 18 April 2023:  An innovative three-step ablation approach including ethanol infusion of the vein of Marshall improves freedom from arrhythmias in patients with persistent atrial fibrillation compared to pulmonary vein isolation (PVI) alone, according to late breaking science presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).1 Preliminary results at 10 months are presented, with follow up ongoing until 12 months.   The cornerstone of catheter ablation of atrial fibrillation is complete isolation of the pulmonary veins.2 However, only 50–60% of patients remain in sinus rhythm at two years.3 Numerous ...

Patients with atrial fibrillation have an average of five additional medical conditions

2023-04-18
Barcelona, Spain – 18 April 2023:  A novel software tool set to improve the management of elderly atrial fibrillation patients with multiple conditions is being designed by the EU-funded and ESC-coordinated EHRA-PATHS consortium. The latest updates on this clinical innovation will be presented at EHRA 2023, a scientific congress of the European Society of Cardiology (ESC).1   Scientific coordinator Professor Hein Heidbuchel said: “EHRA-PATHS is developing a standardised approach to ensure that patients with atrial fibrillation receive evidenced-based therapies for the comorbidities that underlie or complicate their heart rhythm disorder.”   Atrial ...

ARRS Annual Meeting: vascularity, elastography in suspicious TIRADS scores differentiate malignant thyroid nodules

ARRS Annual Meeting: vascularity, elastography in suspicious TIRADS scores differentiate malignant thyroid nodules
2023-04-18
Honolulu, HI | April 18, 2023—Findings from an award-winning Scientific Online Poster presented during the 2023 ARRS Annual Meeting on the island of Oahu determined that assessing the vascularity and elastography in suspect TIRADS categories can efficiently diagnose malignancy of thyroid nodules. Acknowledging that sonographic TIRADS scoring remains the first method of imaging assessment for diagnosing malignant thyroid nodules, “we assessed the added value of shear-wave elastography (SWE) to classic TIRADS assessment,” said Leila Aghaghazvini, MD, from the department of radiology at Shariati Hospital and Iran’s University ...

American Roentgen Ray Society's Roentgen Fund presents 2023 Honorary Lecture, “Advanced High-Resolution CT,” in memory of W. Richard Webb

American Roentgen Ray Societys Roentgen Fund presents 2023 Honorary Lecture, “Advanced High-Resolution CT,” in memory of W. Richard Webb
2023-04-18
Honolulu, HI | April 18, 2023—The American Roentgen Ray Society (ARRS) is pleased to announce that The Roentgen Fund® 2023 Honorary Lecture, “Advanced High-Resolution CT (HRCT),” will be dedicated to W. Richard “Rick” Webb, MD—the late University of California, San Francisco (UCSF) radiologist who transformed the practice of thoracic imaging. Exploring multiple conditions diagnosed via HRCT, as well as the radiologist’s role on today’s multidisciplinary teams, “Advanced HRCT” will take place on Tuesday, April 18, 2023, 1:00–2:20 PM local time, during the 2023 ARRS Annual Meeting in Honolulu, HI. A high-profile presentation ...

Update on the analysis method to estimate the greenhouse gas concentrations from GOSAT

Update on the analysis method to estimate the greenhouse gas concentrations from GOSAT
2023-04-18
1. Background and objectives The Greenhouse gases Observing SATellite (GOSAT) that is the joint mission of the Ministry of Environment, the National Institute for Environmental Studies (NIES), and the Japan Aerospace Exploration Agency has observed almost continuously since its launch and is currently in operation.   Thermal And Near-infrared Sensor for carbon Observation – Fourier Transform Spectrometer (TANSO-FTS) onboard GOSAT observes the shortwave infrared (SWIR) spectra(*1). The carbon dioxide (CO2) and methane (CH4) concentrations can be estimated by ...

Healthcare epidemiologists and infectious diseases experts review changing context for masking in healthcare settings

2023-04-18
The time has come and gone for universal masking in healthcare settings, according to healthcare epidemiologists and infectious diseases experts from healthcare systems throughout Boston and beyond. In a commentary published in Annals of Internal Medicine and co-authored by experts from Mass General Brigham, Beth Israel Lahey Health, Tufts Medicine, the VA Healthcare System Boston, and other healthcare systems across the country, the authors describe the changing context and conditions of the pandemic and outline why universal masking should no longer be required in healthcare settings. “While critically important in the earlier ...

Cardiac arrest in hospital: survival a matter of resources

Cardiac arrest in hospital: survival a matter of resources
2023-04-18
Hospital inpatients have better prospects of surviving a cardiac arrest in large hospitals and well-resourced wards, and daytime cardiac arrests are also associated with better chances of survival, a University of Gothenburg thesis shows. Cardiac arrest means that the heart stops pumping blood. Within seconds, unconsciousness occurs; within minutes, brain cells start dying, causing irreparable damage. The key to enhancing the patients’ chances of survival is restoring the circulation of oxygenated blood in the body. ...

Early study - faecal transplant to help slow early-stage motor neuron disease progression

2023-04-18
A randomised clinical trial is looking at whether faecal microbiota transplantation (FMT) from healthy donors into adults with early-stage amyotrophic lateral sclerosis (ALS – one of the most common forms of motor neurone disease) can modulate the immune reaction during inflammation responses that characterise disease progression, and aims to investigate the relationship between specific gut bacteria and their action on immune system cells. The preliminary findings by Dr Alessandra Guarnaccia from Columbus-Gemelli University Hospital IRCCS, Rome, Italy and ...

Preventing a measles outbreak: steps taken by London hospital to protect patients and staff potentially exposed to the virus

2023-04-18
The steps taken by a London hospital to prevent an outbreak of measles will be detailed at this year’s European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Copenhagen, Denmark (15-18 April). Measles, which is highly contagious, can cause serious and potentially life-threating illness and complications including blindness, encephalitis (swelling of the brain) and pneumonia.  Pregnant women, infants and severely immunocompromised individuals are at highest risk. Contracted when pregnant, it can cause low birth weight babies, premature birth, miscarriage or stillbirth. It usually starts with cold-like symptoms, followed by a rash a few days later.  ...

LAST 30 PRESS RELEASES:

Public confidence in U.S. health agencies slides, fueled by declines among Democrats

“Quantum squeezing” a nanoscale particle for the first time

El Niño spurs extreme daily rain events despite drier monsoons in India

Two studies explore the genomic diversity of deadly mosquito vectors

Zebra finches categorize their vocal calls by meaning

Analysis challenges conventional wisdom about partisan support for US science funding

New model can accurately predict a forest’s future

‘Like talking on the telephone’: Quantum computing engineers get atoms chatting long distance

Genomic evolution of major malaria-transmitting mosquito species uncovered

Overcoming the barriers of hydrogen storage with a low-temperature hydrogen battery

Tuberculosis vulnerability of people with HIV: a viral protein implicated

Partnership with Kenya's Turkana community helps scientists discover genes involved in adaptation to desert living

Decoding the selfish gene, from evolutionary cheaters to disease control

Major review highlights latest evidence on real-time test for blood – clotting in childbirth emergencies

Inspired by bacteria’s defense strategies

Research spotlight: Combination therapy shows promise for overcoming treatment resistance in glioblastoma

University of Houston co-leads $25 million NIH-funded grant to study the delay of nearsightedness in children

NRG Oncology PREDICT-RT study completes patient accrual, tests individualized concurrent therapy and radiation for high-risk prostate cancer

Taking aim at nearsightedness in kids before it’s diagnosed

With no prior training, dogs can infer how similar types of toys work, even when they don’t look alike

Three deadliest risk factors of a common liver disease identified in new study

Dogs can extend word meanings to new objects based on function, not appearance

Palaeontology: South American amber deposit ‘abuzz’ with ancient insects

Oral microbes linked to increased risk of pancreatic cancer

Soccer heading does most damage to brain area critical for cognition

US faces rising death toll from wildfire smoke, study finds

Scenario projections of COVID-19 burden in the US, 2024-2025

Disparities by race and ethnicity in percutaneous coronary intervention

Glioblastoma cells “unstick” from their neighbors to become more deadly

Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer

[Press-News.org] Novel score predicts heart failure improvement after atrial fibrillation ablation
ANTWOORD study presented in a late breaking science session today at EHRA 2023